Overview Financials News + Filings Key Docs Charts Ownership Insiders |
TESARO, Inc. (TSRO)
|
Add to portfolio |
|
|
Price: |
$74.94
| | Metrics |
OS: |
55.0
|
M
| |
|
|
Market cap: |
$4.13
|
B
| |
-1944
|
% ROIC
|
Net debt:
|
$167
|
M
| |
|
|
EV:
|
$4.29
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($602)
|
M
| |
|
|
EBIT
|
($611)
|
M
| |
|
|
EPS |
($11.88)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
Revenues | 270.6 | 61.1 | 4.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | 343.1% | 1298.3% | | | | | -100.0% | |
Cost of goods sold | 47.3 | 3.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 223.3 | 58.0 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | 82.5% | 95.0% | 92.4% | | | | | 0.0% |
Research and development | 308.7 | 235.1 | 155.4 | 118.4 | 75.7 | 47.2 | 11.8 | |
General and administrative | 336.8 | 158.6 | 78.7 | 23.9 | 14.8 | 6.7 | 3.2 | 1.7 |
EBITA | -463.3 | -336.9 | -230.1 | -167.3 | -92.4 | -61.9 | -15.4 | -1.7 |
EBITA margin | -171.2% | -551.5% | -5267.5% | | | | | -3726.1% |
Amortization of intangibles | 6.2 | 1.9 | 0.3 | | | | | |
EBIT | -469.5 | -338.8 | -230.4 | -167.3 | -92.4 | -61.9 | -15.4 | -1.7 |
EBIT margin | -173.5% | -554.7% | -5274.3% | | | | | -3726.1% |
Pre-tax income | -494.8 | -372.7 | -247.7 | -171.0 | -92.4 | -61.8 | -16.4 | -9.0 |
Income taxes | 1.3 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -496.1 | -374.2 | -247.7 | -171.0 | -92.4 | -61.8 | -16.4 | -9.0 |
Net margin | -183.3% | -612.7% | -5671.9% | | | | | -19510.9% |
|
Diluted EPS | ($9.17) | ($7.85) | ($6.29) | ($4.79) | ($2.93) | ($4.51) | ($31.90) | ($26.65) |
Shares outstanding (diluted) | 54.1 | 47.7 | 39.4 | 35.7 | 31.6 | 13.7 | 0.5 | 0.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|